Scientists probe brain with tiny tube to see if drug reaches deadly tumor
NCT ID NCT05413304
Summary
This study aims to see if researchers can measure how much of an oral cancer drug (abemaciclib) gets into a person's aggressive brain tumor. A small number of adults with a recurring high-grade brain tumor will take the drug for a few days before surgery. During surgery, a tiny tube will be placed in the tumor to collect fluid for 48 hours to measure the drug level directly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.